Grantham, Mayo, Van Otterloo & Co. LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1352662
Boston, MA
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$42,767,941
-$1,000,175 QoQ
Shares Held
55,353
-2.4% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $93,420,610 across 9 Biotechnology names. REGN ranks #1 (45.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
55,353 | $42,767,941 | |
| 2 | INCY |
Incyte Corp
|
364,657 | $34,321,516 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
941,266 | $13,610,706 | |
| 4 | EXEL |
Exelixis, Inc.
|
38,235 | $1,639,899 | |
| 5 | ALT |
Altimmune, Inc.
|
126,389 | $389,278 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,182 | $313,207 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
15,444 | $206,486 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
|
16,322 | $112,785 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,767,941 | 55,353 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $43,768,116 | 56,704 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,564,985 | 61,474 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,273,575 | 65,283 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $52,850,385 | 83,330 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,861,831 | 62,979 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $54,661,326 | 51,997 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $60,186,181 | 57,264 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $55,689,671 | 57,860 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $58,933,259 | 67,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $47,682,302 | 57,940 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $38,013,640 | 52,904 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $55,168,567 | 67,142 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $51,328,241 | 71,142 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $37,198,980 | 54,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $33,339,732 | 56,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,454,318 | 47,900 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $29,934,048 | 47,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,835,374 | 49,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,089,190 | 48,500 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $19,682,624 | 41,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,602,445 | 28,156 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $255,259 | 456 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $284,384 | 456 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||